Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2)

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 6640-6646

  Huang, Mei Chuan ^a   Miller, Allison L ^a   Wang, Wengang ^a   Kong, Yvonne ^a   Paul, Sudhir ^b   Goetzl, Edward J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA TRANSFECTION; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH2 CELL; TRANSCRIPTION REGULATION;

EID: 33646867267     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.6640     Document Type: Article

References (16)

1. Martinez, C., M. Delgado, C. Abad, R. P. Gomariz, D. Ganea, and J. Leceta. 1999. Regulation of VIP production and secretion by murine lymphocytes. J. Neuroimmunol. 93: 126-138.
2. Dorsam, G., J. Voice, Y. Kong, and E. J. Goetzl. 2000. Vasoactive intestinal peptide mediation of development and functions of T lymphocytes. Ann. NY Acad. Sci. 921: 79-91.
3. Delgado, M., and D. Ganea. 2001. Cutting edge: is vasoactive intestinal peptide a type 2 cytokine? J. Immunol. 166: 2907-2912.
4. Voice, J. K., G. Dorsam, R. C. Chan, C. Grinninger, Y. Kong, and E. J. Goetzl. 2002. Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide. Regul. Pept. 109: 199-208.
5. Delgado, M., D. Pozo, and D. Ganea. 2004. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol. Rev. 56: 249-290.
6. Delgado, M., E. Gonzalez-Rey, and D. Ganea. 2004. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells. FASEB J. 18: 1453-1455.
7. Mathew, R. C., G. A. Cook, A. M. Blum, A. Metwali, R. Felman, and J. V. Weinstock. 1992. Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection. J. Immunol. 148: 3572-3577.
8. Delgado, M., C. Martinez, M. C. Johnson, R. P. Gomariz, and D. Ganea. 1996. Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R 1 and VIP-R2) mRNA in murine lymphocytes. J. Neuroimmunol. 68: 27-38.
9. Lara-Marquez, M., M. O'Dorisio, T. O'Dorisio, M. Shah, and B. Karacay. 2001. Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. J. Immunol. 166: 2522-2530.
10. Voice, J. K., G. Dorsam, H. Lee, Y. Kong, and E. J. Goetzl. 2001. Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor. FASEB J. 15: 2489-2496.
11. Goetzl, E. J., J. K. Voice, S. Shen, G. Dorsam, Y. Kong, K. M. West, C. F. Morrison, and A. J. Harmar. 2001. Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide. Proc. Natl. Acad. Sci. USA 98: 13854-13859.
12. Grinninger, C., W. Wang, K. B. Oskoui, J. K. Voice, and E. J. Goetzl. 2004. A natural variant type II G protein-coupled receptor for vasoactive intestinal peptide with altered function. J. Biol. Chem. 279: 40259-40262.
13. Goetzl, E. J., D. R. Patel, J. L. Kishiyama, A. C. Smoll, C. W. Turck, N. M. Law, S. A. Rosenzweig, and S. P. Sreedharan. 1994. Specific recognition of the human neuroendocrine receptor for vasoactive intestinal peptide by anti-peptide antibodies. Mol. Cell Neurosci. 5: 145-152.
14. Paul, S., M. Sun, R. Mody, H. K. Tewary, P. Stemmer, R. J. Massey, T. Gianferrara, S. Mehrotra, T. Dreyer, M. Meldal, et al. 1992. Peptidolytic monoclonal antibody elicited by a neuropeptide. J. Biol. Chem. 267: 13142-13145.
15. Voice, J. K., C. Grinninger, Y. Kong, Y. Bangale, S. Paul, and E. J. Goetzl. 2003. Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice. J. Immunol. 170: 308-314.
16. Voice, J., S. Donnelly, G. Dorsam, G. Dolganov, S. Paul, and E. J. Goetzl. 2004. c-Maf and JunB mediation of Th2 differentiation induced by the type 2 G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide. J. Immunol. 172: 7289-7296.